PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $741,000 | -72.3% | 18,495 | -74.2% | 0.00% | -50.0% |
Q1 2022 | $2,674,000 | -6.4% | 71,675 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,858,000 | +164.6% | 71,675 | +214.4% | 0.00% | +100.0% |
Q1 2021 | $1,080,000 | -22.6% | 22,800 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $1,395,000 | +27.7% | 22,861 | -2.1% | 0.00% | 0.0% |
Q3 2020 | $1,092,000 | -56.3% | 23,353 | -52.6% | 0.00% | -66.7% |
Q2 2020 | $2,499,000 | -27.2% | 49,242 | -36.0% | 0.00% | -40.0% |
Q1 2020 | $3,431,000 | -49.4% | 76,902 | -45.5% | 0.01% | -16.7% |
Q4 2019 | $6,783,000 | +42.2% | 141,230 | +0.5% | 0.01% | +20.0% |
Q3 2019 | $4,771,000 | +15.1% | 140,462 | +52.5% | 0.01% | +25.0% |
Q2 2019 | $4,146,000 | +205.1% | 92,122 | +155.1% | 0.00% | +300.0% |
Q1 2019 | $1,359,000 | -48.9% | 36,114 | -53.9% | 0.00% | -66.7% |
Q4 2018 | $2,662,000 | +5.7% | 78,348 | +46.2% | 0.00% | +50.0% |
Q3 2018 | $2,518,000 | +34.3% | 53,585 | -3.6% | 0.00% | 0.0% |
Q2 2018 | $1,875,000 | +173.7% | 55,585 | +119.7% | 0.00% | +100.0% |
Q1 2018 | $685,000 | – | 25,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |